About SEIN
SEIN is a Healthcare company based in Netherlands. Specialized expertise in epilepsy and sleep medicine is provided. It operates on a HealthTech and Professional Services model. Its website sein.nl draws about 57 thousand monthly visits. SEIN offers products and services including Epilepsy Care and Sleep Medicine. Its focus areas include Specialized Medicine and Epilepsy and Sleep Disorders.
Company details
SEIN is established as an expertise center focused on epilepsy and sleep medicine in the Netherlands. Services are provided through outpatient clinics, sleep-wake centers, residential care, day programs, and special education schools. Support is offered to improve the quality of life for individuals affected by epilepsy and sleep disorders. Diagnosis, treatment, and ongoing assistance are tailored to individual needs across multiple sectors of healthcare. Research initiatives are conducted to advance understanding and management of these conditions. Collaboration with specialists ensures comprehensive care and support for patients and their families.
- Headquarters Netherlands
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website sein.nl
- Latest Funding Round$239.15K (USD), Grant
Apr 2023
- Investors
Products & Services of SEIN
SEIN offers a comprehensive portfolio of products and services, including Epilepsy Care and Sleep Medicine.
Specialized care for epilepsy diagnosis and treatment provided.
Diagnosis and treatment for sleep disorders are offered.
Funding Insights of SEIN
- Total Rounds 1
- Last Round Grant β $239,150
- First Round $239,150
(Apr 2023)
- Investors Count 1
All 1 funding rounds of SEIN with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2023 | $239,150 | Grant | β | β |
1 investors in total: 1 institutional.
Investors in SEIN
SEIN has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for SEIN
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Web traffic of SEIN
The website of SEIN (sein.nl) receives about 57.3K visits a month.
- Monthly visits57.3K
▼ 34.5% vs previous month
Websites whose visitors overlap most with SEIN. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| medapp.nl | 100% | 20.2K | #1,299,857 | View details | |
| kempenhaeghe.nl | 82% | 10K | View details | ||
| kwf.nl | 61% | 244.1K | #210,518 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SEIN
SEIN is headquartered in Netherlands.
SEIN is established as an expertise center focused on epilepsy and sleep medicine in the Netherlands. Services are provided through outpatient clinics, sleep-wake centers, residential care, day programs, and special education schools. Support is offered to improve the quality of life for individuals affected by epilepsy and sleep disorders. Diagnosis, treatment, and ongoing assistance are tailored to individual needs across multiple sectors of healthcare. Research initiatives are conducted to advance understanding and management of these conditions. Collaboration with specialists ensures comprehensive care and support for patients and their families.
SEIN offers Epilepsy Care and Sleep Medicine.
SEIN has 1 investor. Key investors include European Union.
